FAKTOR OPTIONSSCHEIN - ASTRAZENECA ADR | Market Closed - Bid/Ask 02:31:55 2024-07-16 am EDT | Pre-market 02:44:29 am | |||
| 4.95 EUR | -0.20% |
|
4.97 | +0.40% |
| Current month | -2.75% | ||
| 1 month | -6.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 4.95 | -0.20% |
| 24-07-15 | 4.96 | -3.50% |
| 24-07-12 | 5.14 | +3.63% |
| 24-07-11 | 4.96 | +0.20% |
| 24-07-10 | 4.95 | +2.70% |
Real-time Boerse Frankfurt Warrants
Last update July 16, 2024 at 02:31 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | UBS |
| WKN | UM5HDP |
| ISIN | DE000UM5HDP5 |
| Date issued | 2024-05-15 |
| Strike | 39.62 $ |
| Maturity | Unlimited |
| Parity | 7.13 : 1 |
| Emission price | 5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.39 € |
|---|---|
| Lowest since issue | 4.76 € |
| Spread | 0.04 € |
| Spread % | 0.80% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
157.2
USD
Average target price
177.6
USD
Spread / Average Target
+13.00%
- Stock Market
- Certificates
- Certificat
